Form 8-K - Current report:
SEC Accession No. 0001048477-25-000049
Filing Date
2025-05-01
Accepted
2025-05-01 16:08:18
Documents
15
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmrn-20250501.htm   iXBRL 8-K 24982
2 EX-99.1 earningsrelease-1may25ex991.htm EX-99.1 266969
6 GRAPHIC imagea.jpg GRAPHIC 198689
  Complete submission text file 0001048477-25-000049.txt   716797

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20250501.xsd EX-101.SCH 1882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20250501_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20250501_pre.xml EX-101.PRE 12603
17 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20250501_htm.xml XML 2712
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 25903129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)